Monopar Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$67.47

+3.08 (+4.78%)

As of Jun 21, 10:24 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target -38.8% upside

Low Target $22.89

Average Target $41.31

High Target $45.20

Current Price $67.47

Current
$67.47

Target
$41.31

$22.89 $41.31 avg $45.20

Scenario Analysis

Bear Case

$22.89

-66.1%

Low target

Base Case

$41.31

-38.8%

Avg target

Bull Case

$45.20

+-33.0%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$105.00

-35.7% from high

52-Week Low

$29.18

+131.2% from low

Target vs 52W High

$41.31

-60.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%